Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta.


Journal

Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 30 04 2021
accepted: 22 01 2022
entrez: 3 11 2022
pubmed: 4 11 2022
medline: 8 11 2022
Statut: ppublish

Résumé

Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA). The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium (Ca2+) ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM). The effect of HCQ on Ca2+ channels was examined using Ca2+-free Krebs solution, and adding calcium chloride (CaCl2 , 10-5- 10-2 M) cumulatively to baths incubated with HCQ. Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of vascular rings was inhibited to a significant degree following the addition of CaCl2 , PE, or KCl on HCQ-incubated RA rings (p < 0.05). The incubation of the RA rings with the Ca2+ channel blocker, the K+ channel blockers, and the COX inhibitor, indomethacin did not significantly affect vascular relaxation induced by HCQ. HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At con-centrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that Ca2+ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.

Sections du résumé

BACKGROUND BACKGROUND
Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA).
METHODS METHODS
The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium (Ca2+) ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM). The effect of HCQ on Ca2+ channels was examined using Ca2+-free Krebs solution, and adding calcium chloride (CaCl2 , 10-5- 10-2 M) cumulatively to baths incubated with HCQ.
RESULTS RESULTS
Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of vascular rings was inhibited to a significant degree following the addition of CaCl2 , PE, or KCl on HCQ-incubated RA rings (p < 0.05). The incubation of the RA rings with the Ca2+ channel blocker, the K+ channel blockers, and the COX inhibitor, indomethacin did not significantly affect vascular relaxation induced by HCQ.
DISCUSSION CONCLUSIONS
HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At con-centrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that Ca2+ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.

Identifiants

pubmed: 36326331
doi: 10.55730/1300-0144.5382
pmc: PMC10390209
doi:

Substances chimiques

NG-Nitroarginine Methyl Ester V55S2QJN2X
Hydroxychloroquine 4QWG6N8QKH
Calcium Chloride M4I0D6VV5M
Indomethacin XXE1CET956
Vasodilator Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

848-857

Références

Br J Pharmacol. 2017 Nov;174(22):4155-4172
pubmed: 28849593
J Smooth Muscle Res. 2003 Jun;39(3):31-7
pubmed: 14572170
J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107
pubmed: 7898101
J Clin Invest. 1998 Aug 1;102(3):595-605
pubmed: 9691096
Clin Exp Pharmacol Physiol. 2014 Apr;41(4):301-8
pubmed: 24552423
Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53
pubmed: 21221847
Cell Physiol Biochem. 2015;37(3):1168-77
pubmed: 26402856
Hypertension. 2014 Aug;64(2):330-7
pubmed: 24842914
Ann Rheum Dis. 2018 Jan;77(1):98-103
pubmed: 28970215
Eur J Clin Pharmacol. 1993;45(1):85-8
pubmed: 8405035
Lupus. 1996 Jun;5 Suppl 1:S2-3
pubmed: 8803902
Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):271-3
pubmed: 15228498
Ann Vasc Surg. 2019 Oct;60:397-406
pubmed: 31200052
Br J Pharmacol. 2020 Jan;177(2):314-327
pubmed: 31503328
J Pharmacol Sci. 2007 Jun;104(2):122-9
pubmed: 17538231
Nat Rev Rheumatol. 2012 Sep;8(9):522-33
pubmed: 22801982
Clin Pharmacol Ther. 1997 Jun;61(6):677-83
pubmed: 9209251
Fundam Clin Pharmacol. 2019 Oct;33(5):504-523
pubmed: 30851197
Nat Rev Rheumatol. 2020 Mar;16(3):155-166
pubmed: 32034323
Nature. 1983 Oct 13-19;305(5935):627-30
pubmed: 6621711
Hypertension. 2009 Mar;53(3):532-8
pubmed: 19188524
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e108-e114
pubmed: 28835487
J Soc Gynecol Investig. 2006 May;13(4):312-5
pubmed: 16697949
J Cardiovasc Pharmacol. 2011 Feb;57(2):133-9
pubmed: 20881603
J Pharmacol Exp Ther. 2007 Mar;320(3):1204-8
pubmed: 17164473
PLoS Med. 2020 Sep 3;17(9):e1003252
pubmed: 32881895
Anesth Analg. 1993 Jan;76(1):24-32
pubmed: 8418736
Ann Rheum Dis. 2018 Oct;77(10):e65
pubmed: 29080860
PLoS One. 2015 Apr 08;10(4):e0123043
pubmed: 25853881
J Pharmacol Sci. 2020 Mar;142(3):101-108
pubmed: 31874782
Heart Rhythm. 2015 Oct;12(10):2186-94
pubmed: 26025323
J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2183-2191
pubmed: 30683593
Basic Clin Pharmacol Toxicol. 2010 Dec;107(6):919-24
pubmed: 20560926

Auteurs

Seyfullah Oktay Arslan (SO)

Department of Medical Pharmacology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Muhammed Fatih Doğan (MF)

Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.

Salih Ayşenur Çam (SA)

Department of Medical Pharmacology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Ibraheem Akram Omar (IA)

Department of Medical Pharmacology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Fatma Uysal (F)

Department of Medical Pharmacology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Ali Parlar (A)

Department of Medical Pharmacology, Faculty of Medicine, Adıyaman University, Adıyaman, Turkey.

Ahmet Cenk Andaç (AC)

Department of Medical Pharmacology, Faculty of Medicine, Yeditepe University, İstanbul, Turkey.

Oğuzhan Yıldız (O)

Department of Medical Pharmacology, Gülhane Faculty of Medicine, Health Sciences University, Ankara, Turkey.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH